title: Myelofibrosis 2012: it's complicated.
abstract: Major advances in myeloproliferative neoplasms in the last decade have cast light on their complexity. The identification of JAK2 (V617F) briefly promised a unifying mechanism of pathogenesis with a single pathway that could be efficiently targeted. Instead, there have been major advances in understanding acquired and background genetic and epigenetic contributors to this group of disorders, with refined risk prediction models and experimental therapeutics that have provided a more nuanced model of disease. In aggregate these observations likely explain the heterogeneity of these disorders and their generally unpredictable response to therapy. Molecular studies, beginning with the identification of JAK2 (V617F), have led to a concept of MPN subtypes existing on a continuum, and additional discoveries such as TET2 and EZH2 mutations have provided the molecular underpinnings to begin to explain overlapping phenotypes in myeloid malignancies more generally. In many ways the pace of molecular discovery is outstripping our ability to integrate these observations into clinical care, both in terms of molecular diagnostics and medical decision making. This review will attempt to summarize, within a clinical context, our evolving understanding of myeloproliferative neoplasms. It focuses on biology, histopathology, prognostic scoring systems, stem cell transplantation as well as selected clinical/preclinical therapeutic observations.
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Harper G
authors.initials: HG
authors.lastname: Hubbeling
authors.forename: Dale M
authors.initials: DM
authors.lastname: Frank
authors.forename: Elizabeth O
authors.initials: EO
authors.lastname: Hexner
keywords: JAK2 V617F; TET2; essential thrombocytosis; hematopoietic stem-cell transplantation; interferon; myelofibrosis; myeloproliferative neoplasms; polycythemia vera
references.citation: Cancer Cell. 2011 Feb 15;19(2):283-94
references.pmid: 21316606
references.citation: N Engl J Med. 2006 Dec 7;355(23):2452-66
references.pmid: 17151367
references.citation: Blood. 2011 Jun 16;117(24):6669-72
references.pmid: 21518929
references.citation: Leukemia. 2008 Apr;22(4):756-61
references.pmid: 18216871
references.citation: PLoS Med. 2006 Jul;3(7):e270
references.pmid: 16834459
references.citation: Blood. 2009 Jul 2;114(1):144-7
references.pmid: 19420352
references.citation: Br J Haematol. 2011 Feb;152(3):331-9
references.pmid: 21133885
references.citation: Lancet. 2005 Mar 19-25;365(9464):1054-61
references.pmid: 15781101
references.citation: Blood. 1996 Aug 1;88(3):1013-8
references.pmid: 8704209
references.citation: Biol Blood Marrow Transplant. 2010 Mar;16(3):358-67
references.pmid: 19879949
references.citation: Blood. 2010 Nov 11;116(19):3735-42
references.pmid: 20664061
references.citation: Nature. 2005 Apr 28;434(7037):1144-8
references.pmid: 15793561
references.citation: Blood. 2011 Nov 10;118(19):5227-34
references.pmid: 21921040
references.citation: N Engl J Med. 2006 Dec 7;355(23):2408-17
references.pmid: 17151364
references.citation: Biol Blood Marrow Transplant. 2007 Mar;13(3):355-65
references.pmid: 17317589
references.citation: Blood. 2010 Sep 2;116(9):1528-38
references.pmid: 20489053
references.citation: Blood. 2011 Jul 7;118(1):167-76
references.pmid: 21531982
references.citation: N Engl J Med. 2010 Sep 16;363(12):1117-27
references.pmid: 20843246
references.citation: Blood. 2008 Jun 15;111(12):5663-71
references.pmid: 17984313
references.citation: J Clin Invest. 2010 Oct;120(10):3578-93
references.pmid: 20852385
references.citation: Nat Med. 2009 Jun;15(6):696-700
references.pmid: 19483695
references.citation: Blood. 2010 Aug 12;116(6):988-92
references.pmid: 20404132
references.citation: Blood. 2010 Oct 14;116(15):2812-21
references.pmid: 20585043
references.citation: Nature. 2009 Oct 8;461(7265):819-22
references.pmid: 19783980
references.citation: Blood. 2009 Mar 26;113(13):2895-901
references.pmid: 18988864
references.citation: Clin Immunol. 2007 Mar;122(3):279-87
references.pmid: 17113348
references.citation: Ther Adv Hematol. 2011 Feb;2(1):11-9
references.pmid: 23556072
references.citation: Nature. 2009 Apr 16;458(7240):904-8
references.pmid: 19212321
references.citation: Nat Rev Drug Discov. 2011 Sep 30;10(10):717-8
references.pmid: 21959272
references.citation: J Clin Oncol. 2011 Mar 1;29(7):789-96
references.pmid: 21220608
references.citation: Blood. 2006 Jun 1;107(11):4274-81
references.pmid: 16478879
references.citation: Cancer Cell. 2005 Apr;7(4):387-97
references.pmid: 15837627
references.citation: Blood. 1999 May 1;93(9):2831-8
references.pmid: 10216077
references.citation: Blood. 2010 Apr 8;115(14):2891-900
references.pmid: 20008300
references.citation: Leukemia. 2010 Aug;24(8):1519-23
references.pmid: 20520643
references.citation: Blood. 2010 Nov 4;116(18):3572-81
references.pmid: 20489052
references.citation: Haematologica. 2011 Oct;96(10):1462-9
references.pmid: 21712540
references.citation: Blood. 2008 Oct 15;112(8):3065-72
references.pmid: 18650451
references.citation: J Natl Cancer Inst. 1960 Jul;25:85-109
references.pmid: 14427847
references.citation: Blood. 2006 Oct 1;108(7):2435-7
references.pmid: 16772604
references.citation: Nat Genet. 2009 Apr;41(4):450-4
references.pmid: 19287385
references.citation: Blood. 2011 May 26;117(21):5710-8
references.pmid: 21447832
references.citation: Blood. 2010 Mar 4;115(9):1703-8
references.pmid: 20008785
references.citation: Blood. 2011 May 5;117(18):4706-15
references.pmid: 21389325
references.citation: Blood. 2005 Oct 15;106(8):2912-9
references.pmid: 15994282
references.citation: Leukemia. 2007 Jan;21(1):183-4
references.pmid: 17096014
references.citation: Ther Adv Hematol. 2011 Feb;2(1):21-32
references.pmid: 23556073
references.citation: Biol Blood Marrow Transplant. 2010 Feb;16(2):281-6
references.pmid: 19786111
references.citation: Blood. 2008 Jul 15;112(2):231-9
references.pmid: 18401028
references.citation: J Clin Oncol. 2011 Feb 1;29(4):392-7
references.pmid: 21149668
references.citation: Nat Genet. 2009 Apr;41(4):385-6
references.pmid: 19338077
references.citation: Leukemia. 2009 Oct;23(10):1924-6
references.pmid: 19440215
references.citation: Cancer Cell. 2011 Jul 12;20(1):11-24
references.pmid: 21723200
references.citation: J Exp Med. 2002 Jun 17;195(12):1599-611
references.pmid: 12070287
references.citation: N Engl J Med. 2007 Feb 1;356(5):459-68
references.pmid: 17267906
references.citation: Blood. 2010 Apr 8;115(14):2919-27
references.pmid: 20154217
references.citation: Cancer Cell. 2011 Jul 12;20(1):25-38
references.pmid: 21723201
references.citation: N Engl J Med. 2011 Jun 30;364(26):2496-506
references.pmid: 21714648
references.citation: Bone Marrow Transplant. 2009 Sep;44(5):317-20
references.pmid: 19234505
references.citation: Blood. 2010 Jan 28;115(4):778-82
references.pmid: 19965680
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):534-40
references.pmid: 19190168
references.citation: Blood. 2010 Jun 3;115(22):4517-23
references.pmid: 20304805
references.citation: Nat Genet. 2009 Apr;41(4):455-9
references.pmid: 19287384
references.citation: Haematologica. 2008 Oct;93(10):1514-22
references.pmid: 18728030
references.citation: Blood. 2005 Jun 15;105(12):4604-12
references.pmid: 15705783
references.citation: Br J Haematol. 2010 Aug;150(4):446-55
references.pmid: 20560970
references.citation: Blood. 2009 Feb 19;113(8):1866-8
references.pmid: 19228938
references.citation: Blood. 2001 Nov 15;98(10):2948-57
references.pmid: 11698276
references.citation: Blood. 2011 Aug 25;118(8):2069-76
references.pmid: 21725052
references.citation: Blood. 2009 Aug 20;114(8):1477-83
references.pmid: 19549988
references.citation: Nat Genet. 2009 Apr;41(4):446-9
references.pmid: 19287382
references.citation: Blood. 2009 Dec 17;114(26):5264-70
references.pmid: 19812383
references.citation: Science. 1997 Jan 17;275(5298):343-9
references.pmid: 8994024
references.citation: Bone Marrow Transplant. 2011 Apr;46(4):557-61
references.pmid: 21042309
references.citation: Biol Blood Marrow Transplant. 2010 Apr;16(4):555-9
references.pmid: 20005966
references.citation: N Engl J Med. 2009 May 28;360(22):2289-301
references.pmid: 19474426
references.citation: Br J Haematol. 2011 Apr;153(1):76-82
references.pmid: 21323890
references.citation: Br J Haematol. 2009 Jul;146(2):223-5
references.pmid: 19545286
references.citation: Br J Haematol. 1997 Jun;97(3):635-40
references.pmid: 9207412
references.citation: J Clin Oncol. 2011 Feb 20;29(6):761-70
references.pmid: 21205761
references.citation: Blood. 1951 Apr;6(4):372-5
references.pmid: 14820991
references.citation: N Engl J Med. 2005 Apr 28;352(17):1779-90
references.pmid: 15858187